Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kazutaka Shimoda
Development of Acute Pancreatitis Caused by Sodium Valproate in a Patient With Bipolar Disorder on Hemodialysis for Chronic Renal Failure: A Case Report
BMC Psychiatry
Psychiatry
Mental Health
Impact of CYP2D6*10 on Venlafaxine and Its Desmethylated Metabolite Pharmacokinetics in Japanese Psychiatric Patients
Proceedings for Annual Meeting of The Japanese Pharmacological Society
Impact of CYP2D6*10 Polymorphism on the Pharmacokinetics of Mirtazapine and Its Desmethylated Metabolite in Japanese Psychiatric Patients Treated With Mirtazapine
Clinical Neuropsychopharmacology and Therapeutics
Psychiatry
Mental Health
Neurology
Pharmacology
A Comparison of Haloperidol Plasma Levels Among Japanese, Korean and Swedish Psychiatric Patients
Clinical Neuropsychopharmacology and Therapeutics
Psychiatry
Mental Health
Neurology
Pharmacology
Rhabdomyolysis After the Administration of Clarithromycin in a Japanese Schizophrenic Patient Receiving Aripiprazole: A Possible Impact of CYP2D6 Genotype
Clinical Neuropsychopharmacology and Therapeutics
Psychiatry
Mental Health
Neurology
Pharmacology
Related publications
Neuropsychiatric Outcomes After Stroke – Authors' Reply
The Lancet Neurology
Neurology
Maximising the Value of Research for Brain Health
The Lancet Neurology
Neurology
Cannabidiol in Patients With Treatment-Resistant Epilepsy
The Lancet Neurology
Neurology
WHO Takes Up the Baton on Dementia
The Lancet Neurology
Neurology
Learning About the Brain With Comics
The Lancet Neurology
Neurology
Functional (Psychogenic) Saccadic Oscillations and Oculogyric Crises – Authors' Reply
The Lancet Neurology
Neurology
Dream Weaver
The Lancet Neurology
Neurology
The Evolution of Universally Accessible Building Design
The Lancet Neurology
Neurology
Global, Regional, and National Burden of Meningitis, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016
The Lancet Neurology
Neurology
Intravenous Immunoglobulin for Treatment of Mild-To-Moderate Alzheimer's Disease: A Phase 2, Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Trial
The Lancet Neurology
Neurology
